Ko Mi Young, Shin Dae Hong, Oh Joung Weon, Asegahegn Workaferhaw Shibru, Kim Kyeong Ho
College of Pharmacy, Kangwon National University, Chunchon 200-701, Korea.
Arch Pharm Res. 2006 Nov;29(11):1061-5. doi: 10.1007/BF02969292.
A new chiral derivatization agent with sugar moiety, 2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl isothiocyanate (GATC) was synthesized. Several beta-blockers were investigated for the possible separation of the enantiomers by reversed-phase HPLC after derivatization with this new chiral derivatization agent (GATC). GATC was reacted readily with beta-blockers at room temperature and the reaction mixture could directly be injected into the HPLC system. The corresponding diastereomers were well resolved on an ODS column with acetonitrile-ammonium acetate buffer as a mobile phase and monitored at UV 254 nm. The optimization of the derivatization procedure (concentration of GATC, reaction temperature and time) and HPLC conditions (pH and ionic strength of mobile phase) were investigated and compared with GITC.
合成了一种带有糖部分的新型手性衍生化试剂,即2,3,4,6-四-O-乙酰基-β-D-吡喃半乳糖异硫氰酸酯(GATC)。研究了几种β-受体阻滞剂在用这种新型手性衍生化试剂(GATC)衍生化后,通过反相高效液相色谱法(HPLC)分离对映体的可能性。GATC在室温下能与β-受体阻滞剂迅速反应,反应混合物可直接注入HPLC系统。相应的非对映体在以乙腈-醋酸铵缓冲液为流动相的ODS柱上得到了很好的分离,并在254nm紫外波长下进行监测。研究了衍生化程序(GATC浓度、反应温度和时间)和HPLC条件(流动相的pH值和离子强度)的优化,并与GITC进行了比较。